betamethasone sodium phosphate (SURF-200) / Harrow Health  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
betamethasone sodium phosphate (SURF-200) / Harrow Health
NCT04734210: Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease

Completed
2
139
US
0.02% Betamethasone Sodium Phosphate, 0.04% Betamethasone Sodium Phosphate, Placebo
Surface Ophthalmics, Inc.
Dry Eye Disease
10/22
10/22

Download Options